PAX6 and aniridia: Similarly, a recent study demonstrated that the MAC-associated variant, S54R, showed sequence-dependent DNA-binding disruption to two characterised PAX6-binding sites, LE9 and SIMO, while aniridia-associated variants such as C52R and S121L consistently ablated DNA-binding (Williamson et al, 2019).